INSIGHTEC's Exablate Neuro Named Best Medical Technology at Esteemed Prix Galien Awards 2017

Haifa, Israel (ots/PRNewswire) - INSIGHTEC
(https://www.insightec.com/), the leader in MR-guided Focused
Ultrasound (MRgFUS), has been awarded Best Medical Technology for
Exablate Neuro by The Galien Foundation. Exablate Neuro is an
innovative medical technology that uses focused ultrasound coupled
with MR imaging (MRgFUS), to precisely target and treat areas deep
within the brain through an intact skull.

The prestigious Prix Galien awards recognize excellence in scientific
innovations that improve the state of human health. The Best Medical
Technology award confirms INSIGHTEC's vision of transformative
healthcare and the company's determination to improve the daily lives
of patients living with essential tremor.

"It's a great honor to receive this award, which recognizes our
dedication to researching and developing a non-invasive medical
treatment," said INSIGHTEC's CEO and Chairman of the Board, Maurice
R. Ferré MD. "Our pursuit of innovation is not only driven by our
founder Kobi Vortman, but also by the leading neurosurgery centers
which have adopted the Exablate Neuro around the world. This is an
exciting time for INSIGHTEC and spurs on our commitment to supporting
healthcare professionals, deliver treatments which truly improve the
lives of people worldwide."

Having accepted the award at The American Museum of Natural History
in New York City, INSIGHTEC's Vice President of Marketing, Xen
Mendelsohn Aderka added "To be seen as an innovator whilst in the
presence of so many renowned figures in the pharmaceutical,
biomedical and medical technology industry, is a great accolade. We
thank the judges for acknowledging the hard work and dedication of
our team."

The U.S. Food and Drug Administration (FDA) approved Exablate Neuro
in July 2016 for the non-invasive treatment of patients with
essential tremor who had not responded to medication. Essential
tremor is the most common movement disorder, affecting more than 5
million people in the United States, and millions more worldwide.
Hand tremor is the most common symptom and for these patients,
performing everyday tasks can seem nearly impossible and greatly
impacts on their quality of life.

About INSIGHTEC

INSIGHTEC is the world leader and innovator of MR-guided Focused
Ultrasound (MRgFUS). The company's non-invasive platforms, Exablate
and Exablate Neuro, are proven technology based on sound clinical
evidence for treating essential tremor, painful bone metastases and
uterine fibroids. The company is dedicated to improving patient lives
by collaborating with physicians, medical institutions, academic
researchers and regulatory bodies around the world. For more
information, please visit: http://www.insightec.com The Neuravive
website for essential tremor patients is
http://usa.essential-tremor.com.

Media Contact:

Michelle Barry

Red Lorry Yellow Lorry for INSIGHTEC

insightec@rlyl.com

+1-857-217-2886

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | PRN

print